INNOVATION PHARMACEUTICALS INC. Diluted Shares Outstanding (Weighted Average)
INNOVATION PHARMACEUTICALS INC. reported Diluted Shares Outstanding (Weighted Average) of 127.29 million shares for the 12-month period ending 2017-06-30, per its 10-K filed 2017-09-11.
Discontinued › Income Statement › Earnings Per Share
us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding · last filed 2017-09-11
- INNOVATION PHARMACEUTICALS INC. weighted average number of shares outstanding, diluted for the quarter ending 2015-09-30 was 115.09M shares, a 9.56% increase year-over-year.
- INNOVATION PHARMACEUTICALS INC. weighted average number of shares outstanding, diluted for the quarter ending 2014-09-30 was 105.04M shares.
- INNOVATION PHARMACEUTICALS INC. weighted average number of shares outstanding, diluted for fiscal 2017 was 127.29M shares, a 6.15% increase from fiscal 2016.
- INNOVATION PHARMACEUTICALS INC. weighted average number of shares outstanding, diluted for fiscal 2016 was 119.91M shares, a 4.19% increase from fiscal 2015.
- INNOVATION PHARMACEUTICALS INC. weighted average number of shares outstanding, diluted for fiscal 2015 was 115.09M shares, a 9.56% increase from fiscal 2014.
- INNOVATION PHARMACEUTICALS INC. weighted average number of shares outstanding, diluted for fiscal 2014 was 105.04M shares.
| Period end | Weighted Average Number of Shares Outstanding, Diluted 3 month | Weighted Average Number of Shares Outstanding, Diluted 12 month |
|---|---|---|
| 2017-06-30 | 127.29M shares 10-K · filed 2017-09-11 | |
| 2016-06-30 | 119.91M shares 10-K · filed 2017-09-11 | |
| 2015-09-30 | 115.09M shares 10-Q · filed 2015-11-09 | |
| 2015-06-30 | 115.09M shares 10-K · filed 2017-09-11 | |
| 2014-09-30 | 105.04M shares 10-Q · filed 2015-11-09 | |
| 2014-06-30 | 105.04M shares 10-K · filed 2016-09-13 | |
| 2013-06-30 | 94.98M shares 10-Q · filed 2015-11-09 | |
| 2012-06-30 | 90.16M shares 10-K · filed 2014-09-15 |